Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 106 (2) , 179-200
- https://doi.org/10.1016/0041-008x(90)90239-q
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injuryJournal of Toxicology and Environmental Health, 1987
- Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicityToxicology and Applied Pharmacology, 1986
- Correlative morphological and biochemical studies on monocrotaline-induced pulmonary alterations in ratsToxicology Letters, 1984
- Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.Thorax, 1982
- EFFECTS OF MONOCROTALINE PRETREATMENT OF RATS ON REMOVAL OF 5‐HYDROXYTRYPTAMINE AND NORADRENALINE BY PERFUSED LUNGBritish Journal of Pharmacology, 1978
- Pulmonary oedema in rats given dehydromonocrotaline: A topographic and electron-microscope studyThe Journal of Pathology, 1975
- Right ventricular hypertrophy in monocrotaline pyrrole treated ratsExperimental and Molecular Pathology, 1974
- An ultrastructural study of the pulmonary lesion induced by pyrrole derivatives of the pyrrolizidine alkaloidsThe Journal of Pathology, 1970
- Lesions in the liver and lungs of rats given pyrrole derivatives of pyrrolizidine alkaloidsThe Journal of Pathology, 1970
- VENTRICULAR WEIGHT IN CARDIAC HYPERTROPHYHeart, 1952